Login
Toggle navigation
Videos
Categories
Trending
Securities are offered through IFP Securities, LLC, while AmeriCorps' CEO shares key remarks in a separate discussion.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
William Hamm, CFA, CFP®, CLU. Chief Executive Officer
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Driving Mongolia Forward: Erdene's Vision for High-Grade Gold Projects
00:10:00
Q1 2024 Market Update: Insights & Predictions | Jason Gunkel - Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
Navigating Alternative Lending: Insights from Blake Albright | Founder and Managing Director at Brightpath Capital
00:00:00
Discussion Group CAP | NICOLÁS BURR G., CHIEF EXECUTIVE OFFICER, CAP SA
00:10:00
In the Canadian Business' Portraits in Leadership program, a reflection on leadership underscores the importance of relationships and understanding others' needs for mutual benefit and growth.|Jean-Louis Servranckx is President and Chief Executive Office
00:10:00
Terna Energy's Strategic Trajectory | Luigi Ferraris, CEO ,Terna Energy SA.
00:10:00
Demands for IT Talents Accelerated by the Pandemic|Keenan Kwok,Co-Founder and Partner,Aera VC
00:10:00
B2Gold Discusses Namibia Gold Project and Global Exploration Plans
00:10:00
DCC's Donal Murphy Addresses Annual Results: Insights and Highlights | Donal Murphy - CEO of DCC plc
00:10:00
"Join Mr. John Lai, CEO & President of PetVivo Holdings, Inc., for a revealing interview on the company's pioneering advancements and strategic vision."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:00:00
Chris Schaber, Soligenix Inc., talks about the collaborative efforts of the industry in response to COVID-19 - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Greenland Minerals: Pioneering Rare Earths and Uranium for a Sustainable Future